BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Wlcus - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Wlcus
X-ORIGINAL-URL:https://wlcus.com
X-WR-CALDESC:Events for Wlcus
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20260101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20270317T080000
DTEND;TZID=UTC:20270318T170000
DTSTAMP:20261103T130716Z
CREATED:20260531T144140Z
LAST-MODIFIED:20261103T130716Z
UID:18383-1805270400-1805389200@wlcus.com
SUMMARY:The Next-Gen Payments Blueprint 2027
DESCRIPTION:European RWE & Market AccessSummit 2027				\n				\n				\n				\n					Loading . . .				\n				\n				\n				\n					October 2027				\n				\n				\n				\n					Agenda under production				\n				\n				\n				\n									\n					\n						\n									Request Agenda\n					\n					\n				\n								\n				\n				\n				\n									\n					\n						\n									Register Now\n					\n					\n				\n								\n				\n					\n		\n					\n		\n		\n		\n		\n				\n				\n					Register Now !				\n				\n				\n				\n		\n				\n				\n					\n		\n			\n                                    \n                        00Days                        00Hours                        00Minutes                                            \n                    \n                                            \n               \n			    \n			\n		\n\n					\n				\n				\n				\n				\n						\n					\n			\n						\n				\n																														\n				\n					\n		\n				\n			\n						\n				\n									\n					The JCA & PICO Strategy				\n			\n						Wlcus\n					European RWE & Market Access Summit 2027\, October 21-22.				\n					\nThe 3rd Annual European RWE & Market Access Summit 2027 is the pharmaceutical industry’s definitive Implementation War Room\, designed to navigate the high-stakes transition into the New European HTA Era. As Joint Clinical Assessments (JCA) become mandatory for oncology and ATMPs\, the mission of this summit is to provide Market Access\, HEOR\, and RWE leaders with a technical roadmap for the critical 100-day submission window. \nThis specialized 2026 edition moves beyond theory\, delivering actionable insights into PICO strategy (Population\, Intervention\, Comparator\, and Outcome)\, bias mitigation\, and the operationalization of DARWIN EU 2.0 for regulatory-grade evidence generation. By attending\, cross-functional teams will master national HTA readiness\, aligning global evidence planning with EMA technical requirements and multi-state payer priorities. From Evidence-to-Access frameworks to solving PICO anxiety\, this summit is the essential briefing for ensuring your 2026–2028 pipeline achieves successful reimbursement and long-term market sustainability across Europe. \n\n				\n							\n				\n					\n		\n					\n		\n		\n					\n		\n				\n				\n									\n					\n						\n									Request Agenda\n					\n					\n				\n								\n				\n				\n		\n				\n				\n									\n					\n						\n									Register Now\n					\n					\n				\n								\n				\n				\n					\n				\n				\n						\n					\n			\n						\n				\n					2027 Strategic Focus				\n				\n				\n				\n									Why This Summit is the Industry’s Definitive “Don’t-Miss” Briefing 								\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					JCA Submission Mastery				\n				\n				\n				\n									Navigate the high-stakes transition into mandatory Joint Clinical Assessments with a tactical roadmap for oncology and ATMP dossiers. Gain the “how-to” on meeting aggressive timelines and ensuring your evidence package is fully compliant with the new 100-day submission window. 								\n				\n					\n		\n				\n			\n						\n				\n					PICO Scoping & Strategy				\n				\n				\n				\n									Eliminate “PICO anxiety” by learning predictive frameworks to anticipate the Population\, Intervention\, Comparator\, and Outcome requirements of diverse Member States. Master the art of bias mitigation and statistical alignment to prevent costly delays in your submission process. 								\n				\n					\n		\n				\n			\n						\n				\n					DARWIN EU 2.0 Operations				\n				\n				\n				\n									Get a direct technical briefing on the EMA’s DARWIN EU network and its transformative role in multi-state data interoperability. Learn to generate “regulatory-grade” evidence that meets the highest standards of data quality and scientific integrity for 2026–2028. 								\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					National HTA Alignment				\n				\n				\n				\n									Solve the challenge of national divergence by aligning global RWE strategies with the specific priorities of local payers and HTA bodies. Transition from broad data collection to precision evidence that addresses country-specific pricing and reimbursement hurdles. 								\n				\n					\n		\n				\n			\n						\n				\n					AI-Driven Evidence Synthesis				\n				\n				\n				\n									Explore the commercial integration of AI and machine learning to streamline RWE operations and automate complex data synthesis. Discover how to reduce the “data-to-submission” lifecycle\, providing your cross-functional teams a competitive edge in rapid-response environments. 								\n				\n					\n		\n				\n			\n						\n				\n					Payer & Regulator Networking				\n				\n				\n				\n									Break down organizational silos by engaging in closed-door discussions with the key architects of the European HTA landscape. Build the high-level networks necessary to influence policy\, understand payer sentiment\, and secure long-term market sustainability for your pipeline. 								\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					\n						European RWE & Market Access Summit 2027\n					Who Should Attend?				\n				\n				\n				\n									Join the Summit in October 								\n				\n				\n				\n							\n							\n											\n													\n										Pharmaceutical Companies\n									\n								\n											\n													\n										Bio-Pharma Companies\n									\n						\n						\n				\n				\n				\n							\n							\n											\n													\n										RWE / HEOR Directors & Leads\n									\n								\n											\n													\n										Market Access Directors & Senior Managers\n									\n								\n											\n													\n										Pricing & Reimbursement Leaders\n									\n								\n											\n													\n										Medical Affairs\n									\n								\n											\n													\n										Evidence Strategy Teams\n									\n								\n											\n													\n										Regulatory Strategy Teams\n									\n								\n											\n													\n										HTA Assessors\n									\n								\n											\n													\n										Real World Data - RWD\n									\n								\n											\n													\n										Real World Evidence - RWE\n									\n								\n											\n													\n										Payer Decision Makers\n									\n								\n											\n													\n										Policy Makers\n									\n								\n											\n													\n										Evidence Reviewers\n									\n								\n											\n													\n										AI in HealthCare Experts\n									\n								\n											\n													\n										RWD Platform Providers\n									\n								\n											\n													\n										Digital Therapeutics Companies\n									\n								\n											\n													\n										Federated Data Networks\n									\n								\n											\n													\n										Evidence Technology Innovators\n									\n								\n											\n													\n										HEOR Modelling Experts\n									\n								\n											\n													\n										Evidence Specialists\n									\n								\n											\n													\n										Health Economists\n									\n								\n											\n													\n										Access Researchers\n									\n						\n						\n				\n					\n		\n				\n			\n						\n				\n																														\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					Our RWE & Pricing Event 2027\, Stats:				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n							\n			Speakers			\n				\n				0\n				+\n			\n		\n						\n				\n					\n		\n				\n			\n						\n				\n							\n			Attendees			\n				\n				0\n				+\n			\n		\n						\n				\n					\n		\n				\n			\n						\n				\n							\n			Companies			\n				\n				0\n				+\n			\n		\n						\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					Meet the Conference Speakers & Thought Leaders				\n				\n				\n				\n									Advisory Board & Thought Leaders  (Coming Soon) 								\n				\n					\n		\n					\n		\n		\n					\n				\n				\n					Join the EU moment Now!				\n				\n					\n				\n		\n					\n		\n				\n				\n																\n															\n															\n				\n				\n		\n				\n				\n																\n															\n															\n				\n				\n					\n				\n		\n					\n				\n				\n					Event 2027 Sponsors\, Exhibitors & Partners				\n				\n					\n				\n		\n					\n				\n				\n							\n			\n					\n						\n				Coming Soon			\n		\n					\n			\n				\n		\n				\n				\n																\n															\n															\n				\n				\n		\n				\n				\n									2027 Partners will be displayed soon. 								\n				\n				\n				\n					\n		\n						\n				\n					\n				\n		\n					\n		\n				\n				\n					Register Now!				\n				\n				\n				\n																														\n				\n				\n		\n				\n				\n					\n                \n                                    Request The Details of The Event\n                                 Reach Us for additional information\, detailed program and pricing\n                        \n\n  \n\n\n\n Name\n \n \n Company\n \n \n Your Phone Number\n \n \n Business email\n \n \n Job Title\n \n \n Choose One\n—Please choose an option—Request AgendaDelegate RegistrationBecome a SpeakerBecome a SponsorBecome Media PartnerOthers \n \n Your Message\n\n\n \n\n \n\n\n\n            				\n				\n				\n					\n				\n		\n					\n				\n				\n					Tickets & Registration will be open soon				\n				\n					\n				\n		\n					\n		\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					2 + 1 Delegates				\n				\n				\n				\n					€ 1199\n€ 1999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					Single Delegate				\n				\n				\n				\n					€ 599\n€ 999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					Single Delegate				\n				\n				\n				\n					€ 1499\n€ 1999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n					Included Accommodation				\n				\n				\n				\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					Single Delegate				\n				\n				\n				\n					€ 1499\n€ 1999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n					Consultants & Solution Providers				\n				\n				\n				\n				\n					\n				\n		\n					\n				\n				\n					Related Videos				\n				\n				\n				\n							\n			\n						\n		\n						\n				\n		\n				\n				\n							\n					\n						\n				\n				\n				\n					Why RWE Can Make or Break Your Drug Launch				\n				\n				\n		\n				\n				\n							\n					\n						\n				\n				\n				\n					RWE is Revolutionizing the Pharma Industry				\n				\n				\n		\n				\n				\n							\n					\n						\n				\n				\n				\n					Drone Technology & Data Insights
URL:https://wlcus.com/event/next-gen-payments-summit-europe/
LOCATION:Amsterdam\, Amsterdam\, Netherlands
CATEGORIES:Fintech
ATTACH;FMTTYPE=image/webp:https://wlcus.com/wp-content/uploads/2026/05/Next-Gen-Payments-Blueprint-Summit-2027.webp
ORGANIZER;CN="Wlcus":MAILTO:booking@wlcus.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20270428T080000
DTEND;TZID=UTC:20270429T170000
DTSTAMP:20261105T132925Z
CREATED:20260620T105003Z
LAST-MODIFIED:20261105T132925Z
UID:18423-1808899200-1809018000@wlcus.com
SUMMARY:Global HSE Nexus 3.0
DESCRIPTION:European RWE & Market AccessSummit 2027				\n				\n				\n				\n					Loading . . .				\n				\n				\n				\n					October 2027				\n				\n				\n				\n					Agenda under production				\n				\n				\n				\n									\n					\n						\n									Request Agenda\n					\n					\n				\n								\n				\n				\n				\n									\n					\n						\n									Register Now\n					\n					\n				\n								\n				\n					\n		\n					\n		\n		\n		\n		\n				\n				\n					Register Now !				\n				\n				\n				\n		\n				\n				\n					\n		\n			\n                                    \n                        00Days                        00Hours                        00Minutes                                            \n                    \n                                            \n               \n			    \n			\n		\n\n					\n				\n				\n				\n				\n						\n					\n			\n						\n				\n																														\n				\n					\n		\n				\n			\n						\n				\n									\n					The JCA & PICO Strategy				\n			\n						Wlcus\n					European RWE & Market Access Summit 2027\, October 21-22.				\n					\nThe 3rd Annual European RWE & Market Access Summit 2027 is the pharmaceutical industry’s definitive Implementation War Room\, designed to navigate the high-stakes transition into the New European HTA Era. As Joint Clinical Assessments (JCA) become mandatory for oncology and ATMPs\, the mission of this summit is to provide Market Access\, HEOR\, and RWE leaders with a technical roadmap for the critical 100-day submission window. \nThis specialized 2026 edition moves beyond theory\, delivering actionable insights into PICO strategy (Population\, Intervention\, Comparator\, and Outcome)\, bias mitigation\, and the operationalization of DARWIN EU 2.0 for regulatory-grade evidence generation. By attending\, cross-functional teams will master national HTA readiness\, aligning global evidence planning with EMA technical requirements and multi-state payer priorities. From Evidence-to-Access frameworks to solving PICO anxiety\, this summit is the essential briefing for ensuring your 2026–2028 pipeline achieves successful reimbursement and long-term market sustainability across Europe. \n\n				\n							\n				\n					\n		\n					\n		\n		\n					\n		\n				\n				\n									\n					\n						\n									Request Agenda\n					\n					\n				\n								\n				\n				\n		\n				\n				\n									\n					\n						\n									Register Now\n					\n					\n				\n								\n				\n				\n					\n				\n				\n						\n					\n			\n						\n				\n					2027 Strategic Focus				\n				\n				\n				\n									Why This Summit is the Industry’s Definitive “Don’t-Miss” Briefing 								\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					JCA Submission Mastery				\n				\n				\n				\n									Navigate the high-stakes transition into mandatory Joint Clinical Assessments with a tactical roadmap for oncology and ATMP dossiers. Gain the “how-to” on meeting aggressive timelines and ensuring your evidence package is fully compliant with the new 100-day submission window. 								\n				\n					\n		\n				\n			\n						\n				\n					PICO Scoping & Strategy				\n				\n				\n				\n									Eliminate “PICO anxiety” by learning predictive frameworks to anticipate the Population\, Intervention\, Comparator\, and Outcome requirements of diverse Member States. Master the art of bias mitigation and statistical alignment to prevent costly delays in your submission process. 								\n				\n					\n		\n				\n			\n						\n				\n					DARWIN EU 2.0 Operations				\n				\n				\n				\n									Get a direct technical briefing on the EMA’s DARWIN EU network and its transformative role in multi-state data interoperability. Learn to generate “regulatory-grade” evidence that meets the highest standards of data quality and scientific integrity for 2026–2028. 								\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					National HTA Alignment				\n				\n				\n				\n									Solve the challenge of national divergence by aligning global RWE strategies with the specific priorities of local payers and HTA bodies. Transition from broad data collection to precision evidence that addresses country-specific pricing and reimbursement hurdles. 								\n				\n					\n		\n				\n			\n						\n				\n					AI-Driven Evidence Synthesis				\n				\n				\n				\n									Explore the commercial integration of AI and machine learning to streamline RWE operations and automate complex data synthesis. Discover how to reduce the “data-to-submission” lifecycle\, providing your cross-functional teams a competitive edge in rapid-response environments. 								\n				\n					\n		\n				\n			\n						\n				\n					Payer & Regulator Networking				\n				\n				\n				\n									Break down organizational silos by engaging in closed-door discussions with the key architects of the European HTA landscape. Build the high-level networks necessary to influence policy\, understand payer sentiment\, and secure long-term market sustainability for your pipeline. 								\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					\n						European RWE & Market Access Summit 2027\n					Who Should Attend?				\n				\n				\n				\n									Join the Summit in October 								\n				\n				\n				\n							\n							\n											\n													\n										Pharmaceutical Companies\n									\n								\n											\n													\n										Bio-Pharma Companies\n									\n						\n						\n				\n				\n				\n							\n							\n											\n													\n										RWE / HEOR Directors & Leads\n									\n								\n											\n													\n										Market Access Directors & Senior Managers\n									\n								\n											\n													\n										Pricing & Reimbursement Leaders\n									\n								\n											\n													\n										Medical Affairs\n									\n								\n											\n													\n										Evidence Strategy Teams\n									\n								\n											\n													\n										Regulatory Strategy Teams\n									\n								\n											\n													\n										HTA Assessors\n									\n								\n											\n													\n										Real World Data - RWD\n									\n								\n											\n													\n										Real World Evidence - RWE\n									\n								\n											\n													\n										Payer Decision Makers\n									\n								\n											\n													\n										Policy Makers\n									\n								\n											\n													\n										Evidence Reviewers\n									\n								\n											\n													\n										AI in HealthCare Experts\n									\n								\n											\n													\n										RWD Platform Providers\n									\n								\n											\n													\n										Digital Therapeutics Companies\n									\n								\n											\n													\n										Federated Data Networks\n									\n								\n											\n													\n										Evidence Technology Innovators\n									\n								\n											\n													\n										HEOR Modelling Experts\n									\n								\n											\n													\n										Evidence Specialists\n									\n								\n											\n													\n										Health Economists\n									\n								\n											\n													\n										Access Researchers\n									\n						\n						\n				\n					\n		\n				\n			\n						\n				\n																														\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					Our RWE & Pricing Event 2027\, Stats:				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n							\n			Speakers			\n				\n				0\n				+\n			\n		\n						\n				\n					\n		\n				\n			\n						\n				\n							\n			Attendees			\n				\n				0\n				+\n			\n		\n						\n				\n					\n		\n				\n			\n						\n				\n							\n			Companies			\n				\n				0\n				+\n			\n		\n						\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					Meet the Conference Speakers & Thought Leaders				\n				\n				\n				\n									Advisory Board & Thought Leaders  (Coming Soon) 								\n				\n					\n		\n					\n		\n		\n					\n				\n				\n					Join the EU moment Now!				\n				\n					\n				\n		\n					\n		\n				\n				\n																\n															\n															\n				\n				\n		\n				\n				\n																\n															\n															\n				\n				\n					\n				\n		\n					\n				\n				\n					Event 2027 Sponsors\, Exhibitors & Partners				\n				\n					\n				\n		\n					\n				\n				\n							\n			\n					\n						\n				Coming Soon			\n		\n					\n			\n				\n		\n				\n				\n																\n															\n															\n				\n				\n		\n				\n				\n									2027 Partners will be displayed soon. 								\n				\n				\n				\n					\n		\n						\n				\n					\n				\n		\n					\n		\n				\n				\n					Register Now!				\n				\n				\n				\n																														\n				\n				\n		\n				\n				\n					\n                \n                                    Request The Details of The Event\n                                 Reach Us for additional information\, detailed program and pricing\n                        \n\n  \n\n\n\n Name\n \n \n Company\n \n \n Your Phone Number\n \n \n Business email\n \n \n Job Title\n \n \n Choose One\n—Please choose an option—Request AgendaDelegate RegistrationBecome a SpeakerBecome a SponsorBecome Media PartnerOthers \n \n Your Message\n\n\n \n\n \n\n\n\n            				\n				\n				\n					\n				\n		\n					\n				\n				\n					Tickets & Registration will be open soon				\n				\n					\n				\n		\n					\n		\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					2 + 1 Delegates				\n				\n				\n				\n					€ 1199\n€ 1999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					Single Delegate				\n				\n				\n				\n					€ 599\n€ 999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					Single Delegate				\n				\n				\n				\n					€ 1499\n€ 1999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n					Included Accommodation				\n				\n				\n				\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					Single Delegate				\n				\n				\n				\n					€ 1499\n€ 1999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n					Consultants & Solution Providers				\n				\n				\n				\n				\n					\n				\n		\n					\n				\n				\n					Related Videos				\n				\n				\n				\n							\n			\n						\n		\n						\n				\n		\n				\n				\n							\n					\n						\n				\n				\n				\n					Why RWE Can Make or Break Your Drug Launch				\n				\n				\n		\n				\n				\n							\n					\n						\n				\n				\n				\n					RWE is Revolutionizing the Pharma Industry				\n				\n				\n		\n				\n				\n							\n					\n						\n				\n				\n				\n					Drone Technology & Data Insights
URL:https://wlcus.com/event/hse_nexus/
LOCATION:Bupdapest\, Hungary
CATEGORIES:Health and Safety
ATTACH;FMTTYPE=image/webp:https://wlcus.com/wp-content/uploads/2026/06/HR26_1920x1080_DesktopHSE.webp
ORGANIZER;CN="Wlcus":MAILTO:booking@wlcus.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20270526T080000
DTEND;TZID=UTC:20270527T170000
DTSTAMP:20260921T191327Z
CREATED:20260620T113808Z
LAST-MODIFIED:20260921T191327Z
UID:18494-1811318400-1811437200@wlcus.com
SUMMARY:Wlcus HR Summit 2027
DESCRIPTION:European RWE & Market AccessSummit 2027				\n				\n				\n				\n					Loading . . .				\n				\n				\n				\n					October 2027				\n				\n				\n				\n					Agenda under production				\n				\n				\n				\n									\n					\n						\n									Request Agenda\n					\n					\n				\n								\n				\n				\n				\n									\n					\n						\n									Register Now\n					\n					\n				\n								\n				\n					\n		\n					\n		\n		\n		\n		\n				\n				\n					Register Now !				\n				\n				\n				\n		\n				\n				\n					\n		\n			\n                                    \n                        00Days                        00Hours                        00Minutes                                            \n                    \n                                            \n               \n			    \n			\n		\n\n					\n				\n				\n				\n				\n						\n					\n			\n						\n				\n																														\n				\n					\n		\n				\n			\n						\n				\n									\n					The JCA & PICO Strategy				\n			\n						Wlcus\n					European RWE & Market Access Summit 2027\, October 21-22.				\n					\nThe 3rd Annual European RWE & Market Access Summit 2027 is the pharmaceutical industry’s definitive Implementation War Room\, designed to navigate the high-stakes transition into the New European HTA Era. As Joint Clinical Assessments (JCA) become mandatory for oncology and ATMPs\, the mission of this summit is to provide Market Access\, HEOR\, and RWE leaders with a technical roadmap for the critical 100-day submission window. \nThis specialized 2026 edition moves beyond theory\, delivering actionable insights into PICO strategy (Population\, Intervention\, Comparator\, and Outcome)\, bias mitigation\, and the operationalization of DARWIN EU 2.0 for regulatory-grade evidence generation. By attending\, cross-functional teams will master national HTA readiness\, aligning global evidence planning with EMA technical requirements and multi-state payer priorities. From Evidence-to-Access frameworks to solving PICO anxiety\, this summit is the essential briefing for ensuring your 2026–2028 pipeline achieves successful reimbursement and long-term market sustainability across Europe. \n\n				\n							\n				\n					\n		\n					\n		\n		\n					\n		\n				\n				\n									\n					\n						\n									Request Agenda\n					\n					\n				\n								\n				\n				\n		\n				\n				\n									\n					\n						\n									Register Now\n					\n					\n				\n								\n				\n				\n					\n				\n				\n						\n					\n			\n						\n				\n					2027 Strategic Focus				\n				\n				\n				\n									Why This Summit is the Industry’s Definitive “Don’t-Miss” Briefing 								\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					JCA Submission Mastery				\n				\n				\n				\n									Navigate the high-stakes transition into mandatory Joint Clinical Assessments with a tactical roadmap for oncology and ATMP dossiers. Gain the “how-to” on meeting aggressive timelines and ensuring your evidence package is fully compliant with the new 100-day submission window. 								\n				\n					\n		\n				\n			\n						\n				\n					PICO Scoping & Strategy				\n				\n				\n				\n									Eliminate “PICO anxiety” by learning predictive frameworks to anticipate the Population\, Intervention\, Comparator\, and Outcome requirements of diverse Member States. Master the art of bias mitigation and statistical alignment to prevent costly delays in your submission process. 								\n				\n					\n		\n				\n			\n						\n				\n					DARWIN EU 2.0 Operations				\n				\n				\n				\n									Get a direct technical briefing on the EMA’s DARWIN EU network and its transformative role in multi-state data interoperability. Learn to generate “regulatory-grade” evidence that meets the highest standards of data quality and scientific integrity for 2026–2028. 								\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					National HTA Alignment				\n				\n				\n				\n									Solve the challenge of national divergence by aligning global RWE strategies with the specific priorities of local payers and HTA bodies. Transition from broad data collection to precision evidence that addresses country-specific pricing and reimbursement hurdles. 								\n				\n					\n		\n				\n			\n						\n				\n					AI-Driven Evidence Synthesis				\n				\n				\n				\n									Explore the commercial integration of AI and machine learning to streamline RWE operations and automate complex data synthesis. Discover how to reduce the “data-to-submission” lifecycle\, providing your cross-functional teams a competitive edge in rapid-response environments. 								\n				\n					\n		\n				\n			\n						\n				\n					Payer & Regulator Networking				\n				\n				\n				\n									Break down organizational silos by engaging in closed-door discussions with the key architects of the European HTA landscape. Build the high-level networks necessary to influence policy\, understand payer sentiment\, and secure long-term market sustainability for your pipeline. 								\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					\n						European RWE & Market Access Summit 2027\n					Who Should Attend?				\n				\n				\n				\n									Join the Summit in October 								\n				\n				\n				\n							\n							\n											\n													\n										Pharmaceutical Companies\n									\n								\n											\n													\n										Bio-Pharma Companies\n									\n						\n						\n				\n				\n				\n							\n							\n											\n													\n										RWE / HEOR Directors & Leads\n									\n								\n											\n													\n										Market Access Directors & Senior Managers\n									\n								\n											\n													\n										Pricing & Reimbursement Leaders\n									\n								\n											\n													\n										Medical Affairs\n									\n								\n											\n													\n										Evidence Strategy Teams\n									\n								\n											\n													\n										Regulatory Strategy Teams\n									\n								\n											\n													\n										HTA Assessors\n									\n								\n											\n													\n										Real World Data - RWD\n									\n								\n											\n													\n										Real World Evidence - RWE\n									\n								\n											\n													\n										Payer Decision Makers\n									\n								\n											\n													\n										Policy Makers\n									\n								\n											\n													\n										Evidence Reviewers\n									\n								\n											\n													\n										AI in HealthCare Experts\n									\n								\n											\n													\n										RWD Platform Providers\n									\n								\n											\n													\n										Digital Therapeutics Companies\n									\n								\n											\n													\n										Federated Data Networks\n									\n								\n											\n													\n										Evidence Technology Innovators\n									\n								\n											\n													\n										HEOR Modelling Experts\n									\n								\n											\n													\n										Evidence Specialists\n									\n								\n											\n													\n										Health Economists\n									\n								\n											\n													\n										Access Researchers\n									\n						\n						\n				\n					\n		\n				\n			\n						\n				\n																														\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					Our RWE & Pricing Event 2027\, Stats:				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n							\n			Speakers			\n				\n				0\n				+\n			\n		\n						\n				\n					\n		\n				\n			\n						\n				\n							\n			Attendees			\n				\n				0\n				+\n			\n		\n						\n				\n					\n		\n				\n			\n						\n				\n							\n			Companies			\n				\n				0\n				+\n			\n		\n						\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					Meet the Conference Speakers & Thought Leaders				\n				\n				\n				\n									Advisory Board & Thought Leaders  (Coming Soon) 								\n				\n					\n		\n					\n		\n		\n					\n				\n				\n					Join the EU moment Now!				\n				\n					\n				\n		\n					\n		\n				\n				\n																\n															\n															\n				\n				\n		\n				\n				\n																\n															\n															\n				\n				\n					\n				\n		\n					\n				\n				\n					Event 2027 Sponsors\, Exhibitors & Partners				\n				\n					\n				\n		\n					\n				\n				\n							\n			\n					\n						\n				Coming Soon			\n		\n					\n			\n				\n		\n				\n				\n																\n															\n															\n				\n				\n		\n				\n				\n									2027 Partners will be displayed soon. 								\n				\n				\n				\n					\n		\n						\n				\n					\n				\n		\n					\n		\n				\n				\n					Register Now!				\n				\n				\n				\n																														\n				\n				\n		\n				\n				\n					\n                \n                                    Request The Details of The Event\n                                 Reach Us for additional information\, detailed program and pricing\n                        \n\n  \n\n\n\n Name\n \n \n Company\n \n \n Your Phone Number\n \n \n Business email\n \n \n Job Title\n \n \n Choose One\n—Please choose an option—Request AgendaDelegate RegistrationBecome a SpeakerBecome a SponsorBecome Media PartnerOthers \n \n Your Message\n\n\n \n\n \n\n\n\n            				\n				\n				\n					\n				\n		\n					\n				\n				\n					Tickets & Registration will be open soon				\n				\n					\n				\n		\n					\n		\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					2 + 1 Delegates				\n				\n				\n				\n					€ 1199\n€ 1999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					Single Delegate				\n				\n				\n				\n					€ 599\n€ 999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					Single Delegate				\n				\n				\n				\n					€ 1499\n€ 1999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n					Included Accommodation				\n				\n				\n				\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					Single Delegate				\n				\n				\n				\n					€ 1499\n€ 1999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n					Consultants & Solution Providers				\n				\n				\n				\n				\n					\n				\n		\n					\n				\n				\n					Related Videos				\n				\n				\n				\n							\n			\n						\n		\n						\n				\n		\n				\n				\n							\n					\n						\n				\n				\n				\n					Why RWE Can Make or Break Your Drug Launch				\n				\n				\n		\n				\n				\n							\n					\n						\n				\n				\n				\n					RWE is Revolutionizing the Pharma Industry				\n				\n				\n		\n				\n				\n							\n					\n						\n				\n				\n				\n					Drone Technology & Data Insights
URL:https://wlcus.com/event/wlcus_hr_summit/
LOCATION:Barcelona\, Spain
CATEGORIES:HR
ATTACH;FMTTYPE=image/webp:https://wlcus.com/wp-content/uploads/2026/06/HR26_1920x1080_Desktop.webp
ORGANIZER;CN="Wlcus":MAILTO:booking@wlcus.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20271021T080000
DTEND;TZID=UTC:20271022T170000
DTSTAMP:20261103T100044Z
CREATED:20261103T093959Z
LAST-MODIFIED:20261103T100044Z
UID:19816-1824105600-1824224400@wlcus.com
SUMMARY:European RWE & Market Access Summit 2027
DESCRIPTION:European RWE & Market AccessSummit 2027				\n				\n				\n				\n					Loading . . .				\n				\n				\n				\n					October 2027				\n				\n				\n				\n					Agenda under production				\n				\n				\n				\n									\n					\n						\n									Request Agenda\n					\n					\n				\n								\n				\n				\n				\n									\n					\n						\n									Register Now\n					\n					\n				\n								\n				\n					\n		\n					\n		\n		\n		\n		\n				\n				\n					Register Now !				\n				\n				\n				\n		\n				\n				\n					\n		\n			\n                                    \n                        00Days                        00Hours                        00Minutes                                            \n                    \n                                            \n               \n			    \n			\n		\n\n					\n				\n				\n				\n				\n						\n					\n			\n						\n				\n																														\n				\n					\n		\n				\n			\n						\n				\n									\n					The JCA & PICO Strategy				\n			\n						Wlcus\n					European RWE & Market Access Summit 2027\, October 21-22.				\n					\nThe 3rd Annual European RWE & Market Access Summit 2027 is the pharmaceutical industry’s definitive Implementation War Room\, designed to navigate the high-stakes transition into the New European HTA Era. As Joint Clinical Assessments (JCA) become mandatory for oncology and ATMPs\, the mission of this summit is to provide Market Access\, HEOR\, and RWE leaders with a technical roadmap for the critical 100-day submission window. \nThis specialized 2026 edition moves beyond theory\, delivering actionable insights into PICO strategy (Population\, Intervention\, Comparator\, and Outcome)\, bias mitigation\, and the operationalization of DARWIN EU 2.0 for regulatory-grade evidence generation. By attending\, cross-functional teams will master national HTA readiness\, aligning global evidence planning with EMA technical requirements and multi-state payer priorities. From Evidence-to-Access frameworks to solving PICO anxiety\, this summit is the essential briefing for ensuring your 2026–2028 pipeline achieves successful reimbursement and long-term market sustainability across Europe. \n\n				\n							\n				\n					\n		\n					\n		\n		\n					\n		\n				\n				\n									\n					\n						\n									Request Agenda\n					\n					\n				\n								\n				\n				\n		\n				\n				\n									\n					\n						\n									Register Now\n					\n					\n				\n								\n				\n				\n					\n				\n				\n						\n					\n			\n						\n				\n					2027 Strategic Focus				\n				\n				\n				\n									Why This Summit is the Industry’s Definitive “Don’t-Miss” Briefing 								\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					JCA Submission Mastery				\n				\n				\n				\n									Navigate the high-stakes transition into mandatory Joint Clinical Assessments with a tactical roadmap for oncology and ATMP dossiers. Gain the “how-to” on meeting aggressive timelines and ensuring your evidence package is fully compliant with the new 100-day submission window. 								\n				\n					\n		\n				\n			\n						\n				\n					PICO Scoping & Strategy				\n				\n				\n				\n									Eliminate “PICO anxiety” by learning predictive frameworks to anticipate the Population\, Intervention\, Comparator\, and Outcome requirements of diverse Member States. Master the art of bias mitigation and statistical alignment to prevent costly delays in your submission process. 								\n				\n					\n		\n				\n			\n						\n				\n					DARWIN EU 2.0 Operations				\n				\n				\n				\n									Get a direct technical briefing on the EMA’s DARWIN EU network and its transformative role in multi-state data interoperability. Learn to generate “regulatory-grade” evidence that meets the highest standards of data quality and scientific integrity for 2026–2028. 								\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					National HTA Alignment				\n				\n				\n				\n									Solve the challenge of national divergence by aligning global RWE strategies with the specific priorities of local payers and HTA bodies. Transition from broad data collection to precision evidence that addresses country-specific pricing and reimbursement hurdles. 								\n				\n					\n		\n				\n			\n						\n				\n					AI-Driven Evidence Synthesis				\n				\n				\n				\n									Explore the commercial integration of AI and machine learning to streamline RWE operations and automate complex data synthesis. Discover how to reduce the “data-to-submission” lifecycle\, providing your cross-functional teams a competitive edge in rapid-response environments. 								\n				\n					\n		\n				\n			\n						\n				\n					Payer & Regulator Networking				\n				\n				\n				\n									Break down organizational silos by engaging in closed-door discussions with the key architects of the European HTA landscape. Build the high-level networks necessary to influence policy\, understand payer sentiment\, and secure long-term market sustainability for your pipeline. 								\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					\n						European RWE & Market Access Summit 2027\n					Who Should Attend?				\n				\n				\n				\n									Join the Summit in October 								\n				\n				\n				\n							\n							\n											\n													\n										Pharmaceutical Companies\n									\n								\n											\n													\n										Bio-Pharma Companies\n									\n						\n						\n				\n				\n				\n							\n							\n											\n													\n										RWE / HEOR Directors & Leads\n									\n								\n											\n													\n										Market Access Directors & Senior Managers\n									\n								\n											\n													\n										Pricing & Reimbursement Leaders\n									\n								\n											\n													\n										Medical Affairs\n									\n								\n											\n													\n										Evidence Strategy Teams\n									\n								\n											\n													\n										Regulatory Strategy Teams\n									\n								\n											\n													\n										HTA Assessors\n									\n								\n											\n													\n										Real World Data - RWD\n									\n								\n											\n													\n										Real World Evidence - RWE\n									\n								\n											\n													\n										Payer Decision Makers\n									\n								\n											\n													\n										Policy Makers\n									\n								\n											\n													\n										Evidence Reviewers\n									\n								\n											\n													\n										AI in HealthCare Experts\n									\n								\n											\n													\n										RWD Platform Providers\n									\n								\n											\n													\n										Digital Therapeutics Companies\n									\n								\n											\n													\n										Federated Data Networks\n									\n								\n											\n													\n										Evidence Technology Innovators\n									\n								\n											\n													\n										HEOR Modelling Experts\n									\n								\n											\n													\n										Evidence Specialists\n									\n								\n											\n													\n										Health Economists\n									\n								\n											\n													\n										Access Researchers\n									\n						\n						\n				\n					\n		\n				\n			\n						\n				\n																														\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					Our RWE & Pricing Event 2027\, Stats:				\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n							\n			Speakers			\n				\n				0\n				+\n			\n		\n						\n				\n					\n		\n				\n			\n						\n				\n							\n			Attendees			\n				\n				0\n				+\n			\n		\n						\n				\n					\n		\n				\n			\n						\n				\n							\n			Companies			\n				\n				0\n				+\n			\n		\n						\n				\n					\n		\n					\n		\n				\n						\n					\n			\n						\n				\n					Meet the Conference Speakers & Thought Leaders				\n				\n				\n				\n									Advisory Board & Thought Leaders  (Coming Soon) 								\n				\n					\n		\n					\n		\n		\n					\n				\n				\n					Join the EU moment Now!				\n				\n					\n				\n		\n					\n		\n				\n				\n																\n															\n															\n				\n				\n		\n				\n				\n																\n															\n															\n				\n				\n					\n				\n		\n					\n				\n				\n					Event 2027 Sponsors\, Exhibitors & Partners				\n				\n					\n				\n		\n					\n				\n				\n							\n			\n					\n						\n				Coming Soon			\n		\n					\n			\n				\n		\n				\n				\n																\n															\n															\n				\n				\n		\n				\n				\n									2027 Partners will be displayed soon. 								\n				\n				\n				\n					\n		\n						\n				\n					\n				\n		\n					\n		\n				\n				\n					Register Now!				\n				\n				\n				\n																														\n				\n				\n		\n				\n				\n					\n                \n                                    Request The Details of The Event\n                                 Reach Us for additional information\, detailed program and pricing\n                        \n\n  \n\n\n\n Name\n \n \n Company\n \n \n Your Phone Number\n \n \n Business email\n \n \n Job Title\n \n \n Choose One\n—Please choose an option—Request AgendaDelegate RegistrationBecome a SpeakerBecome a SponsorBecome Media PartnerOthers \n \n Your Message\n\n\n \n\n \n\n\n\n            				\n				\n				\n					\n				\n		\n					\n				\n				\n					Tickets & Registration will be open soon				\n				\n					\n				\n		\n					\n		\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					2 + 1 Delegates				\n				\n				\n				\n					€ 1199\n€ 1999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					Single Delegate				\n				\n				\n				\n					€ 599\n€ 999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					Single Delegate				\n				\n				\n				\n					€ 1499\n€ 1999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n					Included Accommodation				\n				\n				\n				\n		\n		\n				\n				\n					European				\n				\n				\n				\n					RWE & Market Access				\n				\n				\n				\n					Summit 2026				\n				\n				\n				\n					Amsterdam | Oct. 21-22				\n				\n				\n				\n					Single Delegate				\n				\n				\n				\n					€ 1499\n€ 1999				\n				\n				\n				\n									\n					\n						\n									Buy Now\n					\n					\n				\n								\n				\n				\n				\n					Consultants & Solution Providers				\n				\n				\n				\n				\n					\n				\n		\n					\n				\n				\n					Related Videos				\n				\n				\n				\n							\n			\n						\n		\n						\n				\n		\n				\n				\n							\n					\n						\n				\n				\n				\n					Why RWE Can Make or Break Your Drug Launch				\n				\n				\n		\n				\n				\n							\n					\n						\n				\n				\n				\n					RWE is Revolutionizing the Pharma Industry				\n				\n				\n		\n				\n				\n							\n					\n						\n				\n				\n				\n					Drone Technology & Data Insights
URL:https://wlcus.com/event/european-rwe-market-access-summit-2027/
LOCATION:TBA
CATEGORIES:Pharma
ATTACH;FMTTYPE=image/webp:https://wlcus.com/wp-content/uploads/2026/11/European-RWE-Market-Access-2027.webp
ORGANIZER;CN="Wlcus":MAILTO:booking@wlcus.com
END:VEVENT
END:VCALENDAR